Clinical trial
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
NCT05972564 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
- Lead sponsor
- Vanderbilt University Medical Center
- Phase
- Phase 1/2
- Overall status
- Recruiting
- Start date
- September 6, 2023
- Completion date
- December 30, 2026
- Enrollment
- 74 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.